MedTrace Logo

Extension of the RUSH Protocol for Volume Responsiveness

NCT03285269 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-01-18

No results posted yet for this study

Summary

The current study plants to create a patient registry of patients who present to the emergency department with signs and symptoms of shock and evaluate the ability of a multi-step cardiopulmonary ultrasound protocol to determine the need for fluid therapy.

Conditions

  • Shock

Interventions

DIAGNOSTIC_TEST

Ultrasound Protocol

Ultrasound of the inferior vena cava, heart and lungs.

DEVICE

Bioreactance

Bioreactance assessment using Cheetah Bioreactance Device (FDA Approved). Bioreactance is a non-invasive measure of cardiac output.

PROCEDURE

Passive Leg Raise

A passive leg raise involves placing the patient supine and raising the legs to simulate an intravenous fluid bolus.

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Jason M Fields, MD · Kaiser Permanenete

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2018-11-30
Completion
2018-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03285269 on ClinicalTrials.gov